Results 131 to 140 of about 19,210 (233)

Therapeutic interventions for chronic central serous chorioretinopathy: a comprehensive assessment of systematic reviews

International Journal of Retina and Vitreous
Background A variety of different treatments have been proposed to effectively treat chronic central serous chorioretinopathy but there remains uncertainty regarding the efficacy of a number of treatment options.
Henok Getahun, Rajendra S. Apte
doaj   +1 more source

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration [PDF]

, 2016

core   +1 more source

Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma

Nature Communications
Central serous chorioretinopathy is an eye disease characterized by fluid buildup under the central retina whose etiology is not well understood. Abnormal choroidal veins in central serous chorioretinopathy patients have been shown to have similarities ...
Joel T. Rämö, Bryan R. Gorman, Lu-Chen Weng, Sean J. Jurgens, Panisa Singhanetr, Marisa G. Tieger, Elon HC van Dijk, Christopher W. Halladay, Xin Wang, Blake M. Hauser, Soo Hyun Kim, Joost Brinks, Seung Hoan Choi, Yuyang Luo, FinnGen, VA Million Veteran Program, Saiju Pyarajan, Cari L. Nealon, Michael B. Gorin, Wen-Chih Wu, Scott A. Anthony, David P. Roncone, Lucia Sobrin, Kai Kaarniranta, Suzanne Yzer, Aarno Palotie, Neal S. Peachey, Joni A. Turunen, Camiel JF Boon, Patrick T. Ellinor, Sudha K. Iyengar, Mark J. Daly, Elizabeth J. Rossin   +32 more
doaj   +1 more source

Subretinal lavage to prevent persistent subretinal fluid after rhegmatogenous retinal detachment surgery : a study of feasibility and safety [PDF]

, 2011
Reyniers, Rudolf, Van Aken, Elisabeth, van Meurs, Jan, Veckeneer, Marc, Wong, David   +4 more
core   +2 more sources

Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy

Clinical Ophthalmology, 2012
Fabio MazzolaniPrivate Practice, Milan, ItalyBackground: The purpose of this open-label study was to investigate the effect of a curcumin-phospholipid (lecithin, Meriva®) formulation (Norflo® tablet) on visual acuity and retinal thickness
Mazzolani F
doaj  

Central serous papillopathy by optic nerve head drusen

Clinical Ophthalmology, 2010
Ana Marina Suelves1, Ester Francés-Muñoz1, Roberto Gallego-Pinazo1, Diamar Pardo-Lopez1, Jose Luis Mullor2, Jose Fernando Arevalo3, Manuel Díaz-Llopis1,4,51Department of Ophthalmology, La Fe University Hospital, Valencia,
Ana Marina Suelves, Ester Francés-Muñoz, Roberto Gallego-Pinazo, et al   +3 more
doaj  

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy

Clinical Ophthalmology, 2015
Thuss Sanguansak, Prapapan Pitujaturont, Yosanan Yospaiboon, Suthasinee Sinawat, Tanapat Ratanapakorn, Chavakij Bhoomibunchoo Department of Ophthalmology, Faculty of Medicine, KKU Eye Center, Khon Kaen University, Khon Kaen, Thailand Objective: To ...
Sanguansak T, Pitujaturont P, Yospaiboon Y, Sinawat S, Ratanapakorn T, Bhoomibunchoo C   +5 more
doaj  

Intravitreal injections of corticosteroid and the risk of central serous chorioretinopathy. [PDF]

PLoS One
Song JR, Woo SJ.
europepmc   +1 more source

Treatment of Central Serous Chorioretinopathy With Topical Difluprednate: A Literature Review. [PDF]

Cureus
Chatterjee SK, Khuddus N.
europepmc   +1 more source

Efficacy and Safety of Carbonic Anhydrase Inhibitors in the Management of Central Serous Chorioretinopathy. [PDF]

J Vitreoretin Dis
Abu Serhan H, Ashraf S, Saeed H, Safiullah M, Ul Haq MZ, Shaukat A, Ansari MA, Shah MSU, Ahmed A.   +8 more
europepmc   +1 more source